JPRN-UMIN000006888
Completed
未知
Impact of genetic polymorphism on response to antiviral treatment in patients with hepatitis C - Impact of genetic polymorphism on response to antiviral treatment in patients with hepatitis C
The department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine0 sites3,000 target enrollmentDecember 28, 2011
Conditionshepatitis C
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hepatitis C
- Sponsor
- The department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine
- Enrollment
- 3000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) patients during pregnancy, during breast\-feed, having a plan of pregnancy 2\) patients with autoimmune disease 3\) patients with malignant disease 4\) patients with bleeding tendency (prothorombin time\<50%, platelet count\<30,000/mm3\) 5\) patients disqualified by principal investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effect of genetic polymorphism on antidiabetic medication in Indian patients with Type 2 DiabetesHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/10/058414Chellaram Diabetes Research Centre
Completed
Not Applicable
Genetic polymorphisms and immunologic profiles in arteriogenesisObstructive coronary artery disease and collateral artery growth10011082NL-OMON44569VU University Medical Center50
Completed
Not Applicable
The Genetic variability in the host response to community-acquired pneumonialower respiratory tract infectionpneumonia1000401810024970NL-OMON35629niversitair Medisch Centrum Utrecht2,000
Not yet recruiting
Not Applicable
Heritability in Oropharynx CancerHealth Condition 1: C109- Malignant neoplasm of oropharynx,unspecifiedCTRI/2019/07/020299Department of Health Research
Active, not recruiting
Phase 1
The relationship between genetic polymorphisms in the organic cation transporter genes and the pharmacokinetics and pharmacodynamics of metformin - The genetics of metformin excretioType 2 diabetes mellitusEUCTR2005-000619-85-GBThe University of Liverpool200